These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6482168)

  • 1. Early effects of gentamicin, tobramycin, and amikacin on the human kidney.
    De Broe ME; Paulus GJ; Verpooten GA; Roels F; Buyssens N; Wedeen R; Van Hoof F; Tulkens PM
    Kidney Int; 1984 Apr; 25(4):643-52. PubMed ID: 6482168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative histophotometry analysing significant inductive and alterative effects of aminoglycoside application (gentamicin, tobramycin, amikacin) upon tubular kidney proteins.
    Heinert G; Wyrobnik J; Scherberich J; Mondorf W; Weber W
    Urol Int; 1982; 37(4):221-35. PubMed ID: 6182668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional, histological, biochemical renal modifications. Comparative study of dibekacin, gentamicin, tobramycin, netilmicin and amikacin].
    Viotte G; Olier B; Morin JP; Godin M
    Nouv Presse Med; 1982 Nov; 11(46):3419-25. PubMed ID: 7155850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
    Marks MI; Hammerberg S; Greenstone G; Silver B
    Antimicrob Agents Chemother; 1976 Sep; 10(3):399-401. PubMed ID: 825026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
    Brewer NS
    Mayo Clin Proc; 1977 Nov; 52(11):675-9. PubMed ID: 336988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro studies with netilmicin, amikacin, gentamicin, sissomicin and tobramycin.
    Habwe V; Shadomy S
    J Antimicrob Chemother; 1979 Jan; 5(1):73-9. PubMed ID: 762007
    [No Abstract]   [Full Text] [Related]  

  • 9. Surveillance of aminoglycoside resistance. European data.
    Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
    Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity in vitro of 192 Proteus strains to several aminoglycosides].
    Thaller MC; Berchicchi R; Berlutti F; Maragoni F; Dainelli B
    Ann Sclavo; 1981; 23(1):57-63. PubMed ID: 7294918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combinations of clindamycin with gentamicin, tobramycin, and amikacin against Staphylococcus aureus.
    Watanakunakorn C; Glotzbecker C
    J Antimicrob Chemother; 1980 Nov; 6(6):785-91. PubMed ID: 7440469
    [No Abstract]   [Full Text] [Related]  

  • 13. Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria.
    Seligman SJ
    Antimicrob Agents Chemother; 1978 Jan; 13(1):70-3. PubMed ID: 626492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8.
    Levison ME; Kaye D
    Antimicrob Agents Chemother; 1974 Jun; 5(6):667-9. PubMed ID: 15825423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of cefotaxime and aminoglycosides against enterococci in vitro.
    Elliott AM; Karam GH; Cobbs CG
    Antimicrob Agents Chemother; 1983 Dec; 24(6):847-50. PubMed ID: 6318661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
    Al-Asadi MJ; Towner K; Greenwood D
    J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo acquisition of two different types of aminoglycoside resistance by a single strain of Klebsiella pneumoniae causing severe infection.
    Murray BE; Moellering RC
    Ann Intern Med; 1982 Feb; 96(2):176-80. PubMed ID: 7036812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.
    Dhawan V; Marso E; Martin WJ; Young LS
    Antimicrob Agents Chemother; 1977 Jan; 11(1):64-73. PubMed ID: 836015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
    Keeling KM; Bedwell DM
    J Mol Med (Berl); 2002 Jun; 80(6):367-76. PubMed ID: 12072912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.